A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients

Parkinson's Disease (PD) is a neurodegenerative disorder affecting more than 10 million people worldwide. Currently, PD has no cure and no early diagnostics methods exist. Mitochondrial dysfunction is presented in the early stages of PD, and it is considered an important pathophysiology compone...

Descripción completa

Detalles Bibliográficos
Autores principales: Deus, Cláudia M., Pereira, Susana P., Cunha-Oliveira, Teresa, Teixeira, José, Simões, Rui F., Cagide, Fernando, Benfeito, Sofia, Borges, Fernanda, Raimundo, Nuno, Oliveira, Paulo J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220403/
https://www.ncbi.nlm.nih.gov/pubmed/34147843
http://dx.doi.org/10.1016/j.redox.2021.102037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220403/
https://www.ncbi.nlm.nih.gov/pubmed/34147843
http://dx.doi.org/10.1016/j.redox.2021.102037

Ejemplares similares